StockData
IRTCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

iRhythm Holdings, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$109.60+0.94 (+0.87%)

Close on Oct 19, 2026

Market cap
$3.61B
P/E (TTM)
–
Dividend yield
–

iRhythm Holdings, Inc. revenue by segment

By business segment

By product or service

RevenueQ2 26Q1 26Q4 25Q3 25Q2 25Q1 25Q4 24Q3 24Q2 24Q1 24Q4 23Q3 23% of revenueYoY
Contracted third-party payors$113.78M$106.80M$111.70M$99.01M$97.72M$83.80M$83.32M$77.26M$79.26M$71.77M$70.63M$67.34M50.8%+16.4%
CMS$58.55M$51.39M––$44.48M$38.11M––––––26.1%+31.6%
Customer A$37.78M$30.15M$34.32M$32.79M$31.83M$26.67M$29.85M$23.46M$22.24M$19.57M$18.94M$18.07M16.9%+18.7%
Non-contracted third-party payors$14.06M$11.04M$13.68M$13.52M$12.66M$10.09M$12.82M$10.81M$10.30M$8.80M$8.90M$8.20M6.3%+11.1%
Centers for Medicare and Medicaid––$49.19M$47.56M$44.48M$38.11M$38.34M$36.01M$36.25M$31.79M$34.05M$31.01M––

By region

From the segment and revenue-disaggregation notes of iRhythm's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.